Mets Day 1143: Great article re nivolumab

On the eve of the ASCO conference, the Washington Post has released an interesting article on nivolumab, discussing how it and other immune therapies are changing the course of cancer. Also included is a helpful graphic explaining how nivolumab works. There is also discussion about the cost once they are approved; I'm just happy that I'm in a clinical trial and the drug is working for me.